N,N-Dimethylformamide inhibits high glucose-induced osteoporosis via attenuating MAPK and NF-κB signalling

AIMS: The role of N,N-dimethylformamide (DMF) in diabetes-induced osteoporosis (DM-OS) progression remains unclear. Here, we aimed to explore the effect of DMF on DM-OS development. METHODS: Diabetic models of mice, RAW 264.7 cells, and bone marrow macrophages (BMMs) were established by streptozotoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ya Dong, Liu, Jian Feng, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2022
Materias:
Bone Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057521/
https://www.ncbi.nlm.nih.gov/pubmed/35369730
http://dx.doi.org/10.1302/2046-3758.114.BJR-2020-0308.R2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057521/
https://www.ncbi.nlm.nih.gov/pubmed/35369730
http://dx.doi.org/10.1302/2046-3758.114.BJR-2020-0308.R2

Ejemplares similares